Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study for Treatment of Patients With Relapsed or Primary Refractory Aggressive B- Cell NHL and Anthracycline Chemotherapy Pretreatment, Who Received or Did Not Qualify for Autologous Stem Cell Transplantation.

NCT00385125 is registered in ClinicalTrials.gov with University of Magdeburg as lead sponsor.

NCT NCT00385125
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00385125 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study for Treatment of Patients With Relapsed or Primary Refractory Aggressive B- Cell NHL and Anthracycline Chemotherapy Pretreatment, Who Received or Did Not Qualify for Autologous Stem Cell Transplantation.
Lead sponsor
University of Magdeburg
Phase
Phase 2
Overall status
Unknown status
Start date
August 31, 2004
Completion date
August 31, 2010
Enrollment
30
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lymphoma, high-grade